First American Trust, Fsb Biomarin Pharmaceutical Inc Transaction History

First American Trust, Fsb

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Jan 11, 2018	SELL	$80.76 - $95.13 $1.14 Million - $1.34 Million	-14,099 Closed	0 $0
Q3 2017 Oct 06, 2017	BUY	$80.6 - $94.95 $1.14 Million - $1.34 Million	14,099	14,099 $1.31 Million

636

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of First American Trust, Fsb, based on Form 13F filings with the SEC.

Stay updated on First American Trust, Fsb with notifications on news.